Several genomics firms were among more than 100 that were swept off NASDAQ''''s Biotech Index in January. NASDAQ doesn''''t keep companies with low share volume and stock price in the index. Here''''s how the Genome Technology Index-listed companies that were kicked out and those that cling on were performing on January 19, 2001, the Friday before the cut.
Survivors: Affymetrix, Aurora Biosciences, Gene Logic, Incyte Genomics, Lexicon Genetics, Luminex. Goners: Compugen, DeCode Genetics, Informax, Lynx Therapeutics, Rosetta Inpharmatics, Variagenics.